Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder
Canadian Urological Association Journal · 21.07.2026 · 20 (11)
DOI: 10.5489/cuaj.9576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Urological Association Journal, online erschienen am 21.07.2026. Verfasst von Phillip Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Abstract (Originalsprache)
Introduction
A delay beyond 12 weeks from diagnosis to radical cystectomy (RC) is considered to impart worse oncologic outcomes for patients with muscle-invasive bladder cancer (MIBC); however, no randomized clinical trials have examined this question. We therefore emulated a hypothetical target clinical trial using contemporary data to evaluate the association between time from diagnosis to RC and oncologic outcomes.
Methods
We conducted observational analyses using the National Cancer Database from 2006−2015 to emulate a hypothetical target trial in adults aged 40−79 years with incident cT2−4 N0 M0 urothelial carcinoma of the bladder, treated with RC from 4−18 weeks after diagnosis. We evaluated the association of late RC with pathologic upstaging at RC and overall survival (OS) and conducted exploratory analyses evaluating the association of time to RC with each outcome modeled flexibly.
Results
A total of 3747 patients were included, of which 2992 underwent early RC. Median followup was 32.2 months. In adjusted analyses, late RC was not associated with an increased risk of pathologic upstaging compared to early RC. In addition, there was no statistically significant difference in adjusted OS for late and early RC, respectively. Similar findings were observed across categories of cT stage, age, Charlson index, and gender.
Conclusions
In observational analyses designed to emulate a hypothetical target trial of early vs. late RC, the timing of RC was not associated with a statistically significant increase in pathologic upstaging or a difference in OS when performed from 4−18 weeks after diagnosis. These results suggest the need to re-examine the traditional recommendations for timing of RC following diagnosis.
Autor:innen und Institutionen
- Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, United States.
- Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, United States.
- Division of Urology, University of Colorado Anschutz Medical Center, Aurora, CO, United States.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
- Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Zitieren
APA
Kim, P., Kaul, S., Fleishman, A., Perez-Londono, A., Kim, S., Bellmunt, J., Aghdam, N., Olumi, A. F., Chang, P., Wagner, A., & Gershman, B. (2026). Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder. Canadian Urological Association Journal, 20(11). https://doi.org/10.5489/cuaj.9576
Vancouver
Kim P, Kaul S, Fleishman A, Perez-Londono A, Kim S, Bellmunt J, et al. Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder. Canadian Urological Association Journal. 2026;20(11). doi:10.5489/cuaj.9576
BibTeX
@article{Kim2026,
author = {Kim, Phillip and Kaul, Sumedh and Fleishman, Aaron and Perez-Londono, Agustin and Kim, Simon and Bellmunt, Joaquim and Aghdam, Nima and Olumi, Aria F and Chang, Peter and Wagner, Andrew and Gershman, Boris},
title = {Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder},
journal = {Canadian Urological Association Journal},
year = {2026},
volume = {20},
number = {11},
doi = {10.5489/cuaj.9576}
}
EUVIMED